Progressive Vaccinia: Case Description and Laboratory-Guided Therapy With Vaccinia Immune Globulin, ST-246, and CMX001-Reference-Cited by-同舟云学术

Progressive Vaccinia: Case Description and Laboratory-Guided Therapy With Vaccinia Immune Globulin, ST-246, and CMX001

Published:2012-08-16 Issue:9 Volume:206 Page:1372-1385
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:Journal of Infectious Diseases

Author:

Lederman E. R.,Davidson W.,Groff H. L.,Smith S. K.,Warkentien T.,Li Y.,Wilkins K. A.,Karem K. L.,Akondy R. S.,Ahmed R.,Frace M.,Shieh W.-J.,Zaki S.,Hruby D. E.,Painter W. P.,Bergman K. L.,Cohen J. I.,Damon I. K.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Reference22 articles.

1. Clinical Manifestations of Human Monkeypox Influenced by Route of Infection

2. Duration of antiviral immunity after smallpox vaccination

3. Monkeypox-Induced Immunity and Failure of Childhood Smallpox Vaccination To Provide Complete Protection

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tecovirimat Use under Expanded Access to Treat Mpox in the United States, 2022–2023;NEJM Evidence;2024-09-13

2. Unveiling the Global Surge of Mpox (Monkeypox): A comprehensive review of current evidence;The Microbe;2024-09

3. Mpox and related poxviruses: A literature review of evolution, pathophysiology, and clinical manifestations;Asian Pacific Journal of Tropical Biomedicine;2024-08

4. Identification of the VP37 pocket of monkeypox virus as a promising target for pan-orthopoxvirus inhibitors through virtual screening and antiviral assays;Emerging Microbes & Infections;2024-07-15

5. WITHDRAWN: Monkeypox: A Timely Update on the Global Outbreak, Transmission, Viral Replication, Vaccination and Clinical Strategies;Supramolecular Materials;2024-05